NTPR RADIATION DOSE ASSESSMENT DOCUMENTS - RA02 Accessible Tables

documents Units and Project elements with initial Neutron Doses

Table A1-1: Units and Project Elements with Initial Neutron Doses of 0.001 rem or greater
Unit or Project Element Geometric Mean Dose (rem) Uncertainty Factor Upper-bound Dose (rem)
Operation UPSHOT-KNOTHOLE (1953)
Troop Observers at Shot ANNIE 0.032 2.2 0.071
Troop Observers at Shot NANCY 0.002 1.9 0.004
Troop Observers at Shot SIMON 0.005 2.2 0.012
Battalion Combat Teams A & B at Shot ANNIE 0.032 2.2 0.071
Battalion Combat Teams A & B at Shot SIMON 0.005 2.2 0.012
Operation TEAPOT (1955)
Troop Observers at Shot MOTH 0.32 1.5 0.46
Troop Observers at Shot TESLA 2.7 1.5 4.0
Troop Observers at Shot BEE 0.020 1.5 0.030
Troop Observers at Shot APPLE I 0.048 3.0 0.14
Troop Observers at Shot APPLE II 0.10 3.1 0.31
Marine Brigade (3rd MCPAEB) at Shot BEE 0.020 1.5 0.030
TF RAZOR, 723rd Tank Bn at Shot APPLE II Company A 0.78 0.026 0.28
TF RAZOR, 723rd Tank Bn at Shot APPLE II Company B 3.0 3.4 3.1
TF RAZOR, 723rd Tank Bn at Shot APPLE II Company C 2.4 0.088 0.86
TF RAZOR, Arm Inf Plt at Shot APPLE II Right Flank 0.062 0.020 0.008
TF RAZOR, Arm Inf Plt at Shot APPLE II Center Flank 3.3 3.3 3.3
TF RAZOR, Arm Inf Plt at Shot APPLE II Left Flank 0.21 0.066 0.026
TF RAZOR, Staff Element at Shot APPLE II 0.042 3.3 0.14
Operation PLUMBBOB (1957)
Observers in trenches at Shot PRISCILLA 0.004 3.0 0.012
Observers in trenches 3.8 km from Shot DIABLO 0.011 3.0 0.033
Observers in trenches 3.2 km from Shot KEPLER 0.11 3.0 0.33
Observers in trenches at Shot DOPPLER 0.54 3.0 1.7
Task Force BIG BANG at Shot GALILEO 0.020 3.0 0.060
Task Force WARRIOR at Shot DOPPLER 0.54 3.0 1.7
Operation HARDTACK II (1958)
1352nd Motion Picture Squadron at Shot HAMILTON NR1 NR NR
Operation DOMINIC II (1962)
IVY FLATS Maneuver Troops and Military Observers at Shot LITTLE FELLER I NR NR NR

1 “NR” indicates that the dose and upper bound have not been reconstructed although the dose may be 0.001 rem or greater.

 

documents Doses from Initial Gamma Radiation for NTPR Participants

Table A1-2: Doses from Initial Gamma Radiation for NTPR Participants
Unit or Project Element Initial Gamma Dose(rem)
Mean Dose UB Dose*
Operation BUSTER-JANGLE (1951)
All ground-based military personnel at all shots <0.001 <0.001
Operation TUMBLER-SNAPPER (1952)
All ground-based military personnel at all shots <0.001 <0.001
Operation UPSHOT-KNOTHOLE (1953)
Troop Observers at Shot ANNIE 0.019 0.057
Troop Observers at Shot NANCY 0.007 0.021
Troop Observers at Shot BADGER 0.010 0.030
Troop Observers at Shot SIMON 0.015 0.045
Troop Observers at Shots ENCORE and GRABLE <0.001 <0.001
Troop Observers at Shot HARRY 0.013 0.039
Battalion Combat Teams A & B at Shot ANNIE 0.012 0.036
Battalion Combat Teams A & B at Shot NANCY 0.004 0.012
Battalion Combat Teams A & B at Shot SIMON 0.012 0.036
Battalion Combat Teams A & B at Shots ENCORE and GRABLE <0.001 <0.001
Marine Brigade (2nd MCPAEB) at Shots DIXIE and RAY <0.001 <0.001
Marine Brigade (2nd MCPAEB) at Shot BADGER 0.006 0.018
Operation TEAPOT (1955)
Observers at Shot MOTH 0.083 0.25
Observers at Shot TESLA 0.32 0.96
Observers at Shot TURK <0.001 <0.001
Observers at Shot BEE 0.029 0.087
Observers at Shot APPLE I 0.045 0.14
Observers at Shot APPLE II 0.082 0.25
VIP Observers at Shot APPLE II 0.002 0.006
Marine Brigade (3rd MCPAEB) at Shot BEE 0.02 0.06
TF RAZOR, 723rd Tank Bn at Shot APPLE II Company A 0.17 0.51
TF RAZOR, 723rd Tank Bn at Shot APPLE II Company B 0.026 0.078
TF RAZOR, 723rd Tank Bn at Shot APPLE II Company C 0.1 0.3
TF RAZOR, Arm Inf Plt at Shot APPLE II Right Flank 0.17 0.51
TF RAZOR, Arm Inf Plt at Shot APPLE II Center Flank 0.11 0.33
TF RAZOR, Arm Inf Plt at Shot APPLE II Left Flank 0.058 0.18
TF RAZOR, Tank Command Group at Shot APPLE II 0.14 0.42
TF RAZOR, Staff Element at Shot APPLE II 0.15 0.45
TF RAZOR, Engineer Platoon at Shot APPLE II 0.01 0.03
TF RAZOR, Artillery Battery at Shot APPLE II <0.001 <0.001
TF RAZOR, Observers at Shot APPLE II <0.001 <0.001
Operation PLUMBBOB (1957)
Observers in trenches at Shot PRISCILLA 0.005 0.015
Observers in trenches at Shot HOOD 0.002 0.006
Observers in trenches 3.8 km from Shot DIABLO 0.007 0.021
Observers in trenches 3.2 km from Shot KEPLER 0.025 0.075

* Mean initial gamma doses are multiplied by an uncertainty factor of 3 to obtain an upper-bound (UB) dose (Weitz and Egbert, 2010). Upper-bound initial gamma doses were not included in Weitz and Egbert (2010).

 

Cross-Reference of Diseased Organs, NTPR Standard Organs, and NIOSH-IREP Cancer Models*

Table A2-1: Cross-Reference of Diseased Organs, NTPR Standard Organs, and NIOSH-IREP Cancer Models*
Organ, Tissue, or Disease NTPR Standard Organ NTPR Standard Organ Type† NIOSH-IREP Cancer Model
Acute lymphocytic leukemia (ALL) Red Marrow Surrogate Acute Lymphocytic Leukemia
Acute myeloid leukemia (AML) Red Marrow Surrogate Acute Myeloid Leukemia
Acute or chronic diastolic heart failure Muscle Surrogate Not applicable (not a malignant neoplasm)
Adrenal glands Adrenals FIIDOS Endocrine glands, other than thyroid
Ampullary cancer SI Wall Surrogate All digestive
Arthritic tissue Bone Surface Surrogate Not applicable (not a malignant neoplasm)
Asthma Lung Surrogate Not applicable (not a malignant neoplasm)
Atrial fibrillation Muscle Surrogate Respiratory tract, other than lung
Bladder Urinary Bladder Wall FIIDOS Bladder
Blood, bone marrow, red marrow, yellow marrow Red Marrow FIIDOS, Surrogate Leukemia, excluding ALL, AML, CML, and CLL
Bone, bone surface, endosteum, joints, and all other bones (e.g., ankle, elbow, femur, hand, jaw, pelvis, shoulder, spine, vertebrae) Bone Surface FIIDOS, Surrogate Bone
Brain, anterior commissure, brain stem, cranial nerve Brain FIIDOS, Surrogate Nervous system
Breast Breast FIIDOS Breast
Cervix Uterus Surrogate Female Genitalia, excluding ovary
Chronic lymphocytic leukemia (CLL) Spleen Surrogate Chronic Lymphocytic Leukemia
Chronic myeloid leukemia (CML) Red Marrow Surrogate Chronic Myeloid Leukemia
Claudication (Muscle cramps) Muscle Surrogate Not applicable (not a malignant neoplasm)
Connective tissue Muscle Surrogate Connective tissue
COPD, non-radiogenic Lung Surrogate Not applicable (not a malignant neoplasm)
Coronary artery disease Muscle Surrogate Not applicable (not a malignant neoplasm)
Diabetes (type 1, type 2) Pancreas Surrogate Not applicable (not a malignant neoplasm)
Dysphonia ET Region Surrogate Not applicable (not a malignant neoplasm)
Endocrine glands (endocrine glands not included elsewhere) Specific diseased organ must be known. Surrogate Endocrine glands other than thyroid
Esophagus ET Region‡ FIIDOS Esophagus
Eye, choroid, retina Brain Surrogate Eye
Gallbladder, bile duct Liver Surrogate Gallbladder
Heart, aorta, atrial sarcoma Muscle Surrogate Respiratory tract, other than lung
Hemoptysis ET Region Surrogate Not applicable (not a malignant neoplasm)
Hypertension (high blood pressure) Muscle Surrogate Not applicable (not a malignant neoplasm)
Kidney Kidney FIIDOS Urinary organs, excluding bladder
Kidney, chronic disease Kidney FIIDOS Not applicable (not a malignant neoplasm)
Larynx, including glottis, vocal cords ET Region‡ Surrogate Respiratory tract, other than lung
Leiomyosarcoma Muscle Surrogate Other and ill-defined sites
Leukemia (excluding ALL, AML, CLL, and CML)‡ Red Marrow Surrogate Leukemia, excluding ALL, AML, CML, and CLL
Lipoma Muscle Surrogate Not applicable (not a malignant neoplasm)
Liver Liver FIIDOS Liver
Lower large intestine, colon, large intestine LLI Wall‡ FIIDOS, Surrogate Colon
Lung, trachea Lung FIIDOS, Surrogate Lung
Lymph system, including lymph glands, lymph nodes, lymphatic tissue, lymphoma Thymus (If this is primary disease) Surrogate Lymphoma and multiple myeloma
Middle ear Brain Surrogate Respiratory tract, other than lung
Monoclonal B-cell lymphocytosis Spleen Surrogate Pre-cancer
Multiple myeloma Red Marrow Surrogate Lymphoma and multiple myeloma
Muscle, including, thigh muscle, eye muscle, eyelid muscle, neuro-muscular Muscle FIIDOS, Surrogate Other and ill-defined sites
Myelodysplastic syndrome Red Marrow Surrogate Acute Myeloid Leukemia
Nasal cavities, including sinus (maxillary), sinus (nasal), nasal tip ET Region‡ Surrogate Respiratory tract, other than lung
Nervous system, spinal cord, spine nerves Brain Surrogate Nervous system
Neuroendocrine system, including hypothalamus, pituitary gland, pineal gland Brain Surrogate Endocrine glands other than thyroid
Oral cavity and pharynx, including epiglottis, gum, hypopharynx, lip, mouth, nasopharynx, oropharynx, palate, parotid gland, pharynx, salivary gland, throat, tongue, tonsil, uvula, and nasolabial fold (specific disease needed if not skin cancer) ET Region‡ Surrogate Oral Cavity and Pharynx
Ovary Ovary FIIDOS Ovary
Pancreas Pancreas FIIDOS Pancreas
Parathyroid Thyroid Surrogate Endocrine glands other than thyroid
Parkinson's disease Brain Surrogate Not applicable (not a malignant neoplasm)
Peritoneum, peritoneal cavity muscle Muscle Surrogate All digestive, other than esophagus, stomach, colon, and rectum/anus
Pleura Lung Surrogate Respiratory tract, other than lung
Prostate Testes Surrogate All Male Genitalia
Pulmonary embolism Muscle Surrogate Not applicable (not a malignant neoplasm)
Rectum, anus, anal canal LLI Wall‡ Surrogate Rectum
Respiratory other than Lung ET Region‡ Surrogate Respiratory tract, other than lung
Restless leg syndrome (RLS) Brain Surrogate Not applicable (not a malignant neoplasm)
Retinopathy Brain Surrogate Not applicable (not a malignant neoplasm)
Small intestine, duodenum SI Wall‡ FIIDOS, Surrogate All digestive, other than esophagus, stomach, colon, and rectum/anus
Soft tissue, e.g., hip, shoulder, thigh, upper-arm Muscle Surrogate Other and ill-defined sites
Spleen Spleen (Use only if solid cancer of spleen is the primary disease) FIIDOS All digestive, other than esophagus, stomach, colon, and rectum/anus
Stomach Stomach Wall FIIDOS Stomach
Stroke Muscle Surrogate Not applicable (not a malignant neoplasm)
Testes and other male genitalia, including penis, scrotum Testes FIIDOS, Surrogate All Male Genitalia
Thoracic sarcoma, Malignant Muscle Surrogate Connective tissue
Thymus Thymus FIIDOS Respiratory tract, other than lung
Thyroid Thyroid FIIDOS Thyroid
Upper large intestine, including appendix, cecum ULI Wall‡ FIIDOS, Surrogate Colon
Urinary tract, urethra, ureter Urinary Bladder Wall Surrogate Urinary organs, excluding bladder
Viral cardiomyopathy Muscle Surrogate Not applicable (not a malignant neoplasm)
 

General Exclusions Applicable to Pacific Proving Ground Ship-based Personnel*

Table A5-1: General Exclusions Applicable to Pacific Proving Ground Ship-based Personnel*
Activity or Cohort
Participation in more than one test series (operation)
Decontamination of any equipment (except for CROSSROADS target ship crews)
Personnel who performed maintenance or repair on contaminated equipment prior to decontamination
Personnel who were topside during one or more fallout events and thus may have inhaled descending fallout
Personnel whose regular assignment was to a small boat crew
Divers
Crews of cloud-tracking or cloud-sampling aircraft
Involvement in or near heliborne operations (crew members or passengers)
Radioactive sample recovery, handling, or preparation
Personnel who were assigned to support scientific projects (e.g., weapon development projects or effects experiments)
Personnel whose regular assignment was to a Radiological Safety (Rad-Safe) unit
Flight drone or sounding rocket operations
Personnel assigned to ships that experienced evaporator or potable water system failures that lead to contaminated drinking water
Shore excursion to any island where a test shot was performed
Consumption of meals while topside during episodes of descending fallout
Individuals with film badge records and whose total film badge dose is greater than the EPG external dose determined for their respective EPG

These exclusions apply unless otherwise stated for a specific EPG as described in the Compendium of Proposed EPGs (Case et al., 2011b).

 

General Exclusions Applicable to Pacific Proving Ground Land-Based Personnel*

Table A5-2: General Exclusions Applicable to Pacific Proving Ground Land-Based Personnel*
Activity or Cohort
Participation in more than one testing series (operation)
Decontamination of aircraft, helicopters, vehicles, or equipment
Personnel who performed maintenance or repair on contaminated aircraft, helicopters, vehicles, or equipment prior to decontamination
Personnel whose regular assignment was to a small boat crew
Divers
Crews of cloud-tracking, cloud-sampling, or air delivery aircraft
Involvement in or near heliborne operations (crew members or passengers)
Radioactive sample recovery, handling, or preparation
Personnel who were assigned to support scientific projects, e.g., weapon development projects or effects experiments (except if participation was as Bikini Resurvey personnel in 1947)
Personnel whose regular assignment was to a Radiological Safety (Rad-Safe) unit
Flight drone or sounding rocket operations
Excursion to any island where a test shot was performed
Consumption of meal(s) while outside during episodes of descending fallout at their location
Individuals with film badge records and whose total film badge dose is greater than the EPG external dose determined for their respective EPG

These exclusions apply unless otherwise stated for a specific EPG as described in the Compendium of Proposed EPGs (Case et al., 2011b).

 

General Exclusions Applicable to Participants During Testing at the Nevada Test Site*

Table A5-3: General Exclusions Applicable to Participants During Testing at the Nevada Test Site*
Activity or Cohort
Participation in more than one testing series (operation)
Volunteer observers
Participation in decontamination of aircraft, helicopters, vehicles, or equipment
Personnel who performed maintenance or repair on contaminated aircraft, helicopters, vehicles, or equipment prior to decontamination
Crews of cloud-tracking, cloud-sampling, or air-delivery aircraft
Members of helicopter crews
Radioactive sample recovery, handling, or preparation
Personnel whose regular assignment was to a Radiological Safety (Rad-Safe) unit
Personnel who were assigned duties in the forward test area for any reason other than to observe a shot or participate in a maneuver (e.g., Instructor/Control, Signal, Transportation, Engineering, etc.)
Personnel who were assigned to support scientific projects (e.g., weapons development projects and military or civil effects projects)
Consumption of meals while outside during episodes of descending fallout
Individuals with film badge records and whose total film badge dose is greater than the maximized upper-bound external dose determined for their respective EPG

These exclusions apply unless otherwise stated for a specific EPG as described in the Compendium of Proposed EPGs (Case et al., 2011b).

 

Expedited Processing Groups for Operation CROSSROADS (1946)

Table A5-4: Expedited Processing Groups for Operation CROSSROADS (1946)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)‡ Number of Participants (Approx.)
CROSSROADS Support Ship-Based Personnel Crews of CROSSROADS support ships, and crews of the re-manned target ships USS BLADEN, USS CORTLAND, USS FILLMORE, USS GENEVA, USS NIAGARA, and USS LCI(L)615. Target ship boardings after BAKER (distinct EPG, see below). / Flight/drone operations aboard USS SHANGRI-LA and USS SAIDOR. / USS BRUSH (distinct EPG, see below). / Ammunition Disposal Units at Kwajalein (Post-XRD). / Bikini resurvey (distinct EPG, see below). / Crew member of the USS ACHOMAWI, USS COUCAL, and USS O'BRIEN. USS RECLAIMER† 1.7§ 30,000
CROSSROADS Land-Based Personnel Land-based personnel at Kwajalein and Enewetak Atolls and weather station islands (there were no land-based personnel at Bikini Atoll). Decontamination of target ships moored at Kwajalein Island. / Towing of target ships to Kwajalein Island. / Small boat operations involving contaminated target or support ships moored at Kwajalein Island. / Performing surveys, construction, or experiments on Bikini Atoll after Shot ABLE. / Unloading, inspecting, handling, moving, and decontaminating ammunition on target ships moored at Kwajalein Island. / Handling of contaminated clothing, waste, or equipment created during ammunition inspection and unloading operations at Kwajalein Island. Army Air Group TG 1.5 0.1 2,600
CROSSROADS Target Ship-Based Personnel Crews that boarded contaminated target ships after Shot BAKER. Crews of six re-manned target ships that did not receive topside contamination from Shot BAKER: USS BLADEN, USS CORTLAND, USS FILLMORE, USS GENEVA, USS NIAGARA, and USS LCI(L)-615. These personnel are included in the CROSSROADS Support Ship-Based Personnel EPG. / Crew members of any target ships who did not participate in target ship boardings after Shot BAKER – these personnel are included in the CROSSROADS Support Ship Crew EPG. / Crew members of any target ships who were subsequently assigned to Ammunition Disposal Units and participated in ammunition unloading at Kwajalein. / Personnel who were crew members of target submarines. USS CARTERET 2.9 (previous RDA) 8,000
USS BRUSH Crew (February 25-27, 1947) Crew of USS BRUSH in Kwajalein Lagoon, February 1947. Personnel who transferred to USS BRUSH after the ship's departure from Kwajalein Atoll on February 27, 1947. Crew members who participated in excursions to target ships. 0.07 (previous RDA) 250
Bikini Resurvey Personnel July-August 1947 Crew members of USS CHILTON, USS COUCAL and LCI(L)-615 who participated as members of the Bikini Resurvey team in July and August 1947. None specific to this group. Navy Construction Battalion Detachment 1800. 0.8 (previous RDA) 700

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† Crews of USS O’BRIEN received limited fallout after ABLE, in addition to BAKER’s. The corresponding external dose when added to that due to exposure to BAKER fallout is smaller than that for the USS RECLAIMER. USS ACHOMAWI and possibly other support ships had faulty evaporators that may have resulted in an additional internal dose due to ingestion of contaminated drinking water.
‡ These are not assigned doses to members of EPGs (see introductory narrative of this attachment).
§ See DNA-TR-82-05-V1, Analysis of Radiation Exposure for Naval Units of Operation CROSSROADS; Volume 1-Basic Report (March 3, 1982), including Table 7-1 for external dose estimate.

 

Expedited Processing Groups for Operation SANDSTONE (1948)

Table A5-5: Expedited Processing Groups for Operation SANDSTONE (1948)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)† Number of Participants (Approx.)
SANDSTONE Ship-Based Personnel Personnel on ships during Operation SANDSTONE to include transient ships. Individuals who participated in Enewetak and Bikini Atoll resurveys (Post-SANDSTONE). / Individuals who Boarded Operation CROSSROADS target ships moored at Kwajalein. / Individuals who participated in a special project known as Operation FITZWILLIAM that involved laboratory measurements of radioactive samples. USS HENRY W. TUCKER 0.05 6,400
SANDSTONE Land-Based Personnel Army, Navy, and Air Force personnel stationed at Enewetak and Kwajalein Atolls. Individuals who participated in Enewetak and Bikini Atoll resurveys (Post-SANDSTONE). / Individuals who boarded Operation CROSSROADS target ships moored at Kwajalein. / Individuals who participated in a special project known as Operation FITZWILLIAM that involved laboratory measurements of radioactive samples. / Individuals who were stationed at Majuro Atoll, Rongerik Atoll, or Wake Island. TG 7.4 (Air Force) at Kwajalein Atoll 0.08 5000

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). See “Appendix B-2, Operation SANDSTONE” of the NTPR/RDA SOP Manual for estimated dose.

 

Expedited Processing Groups for Operation GREENHOUSE (1951)

Table A5-6: Expedited Processing Groups for Operation GREENHOUSE (1951)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)† Number of Participants (Approx.)
GREENHOUSE Ship-Based Personnel Personnel on ships during Operation GREENHOUSE including transient ships. No specific exclusions. USNS SGT. C. E. MOWER 0.68 4,700
GREENHOUSE Land-Based Personnel Army, Navy, and Air Force personnel stationed at Enewetak Atoll, Kwajalein Atoll, and weather station islands. Individuals who participated in clothing contamination tests. Headquarters, Joint Task Force-3 3.1 4,700

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). See “Appendix B-3, Operation GREENHOUSE” of the NTPR/RDA SOP Manual for estimated doses.

 

Expedited Processing Groups for Operation IVY (1952)

Table A5-7: Expedited Processing Groups for Operation IVY (1952)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)† Number of Participants (Approx.)
IVY Ship-Based Personnel Personnel on ships during Operation IVY including transient ships. None specific to this group. USS LIPAN 0.036 4,700
IVY Land-Based Personnel Army, Navy, and Air Force personnel stationed at the residence islands of Enewetak Atoll, Kwajalein Atoll, and weather station islands. None specific to this group. 7126th Army Unit on Enewetak Atoll. 0.059 4,700

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). See “Appendix B-4, Operation IVY” of the NTPR/RDA SOP Manual for estimated doses.

 

Expedited Processing Groups for Operation CASTLE (1954)

Table A5-8: Expedited Processing Groups for Operation CASTLE (1954)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)† Number of Participants (Approx.)
CASTLE High-Dose Ship-Based Personnel Personnel on Operation CASTLE ships that received heavier fallout. Personnel on Operation CASTLE ships that received light fallout to include transient ships (distinct EPG, see below). / Shore excursions on Rongelap or Rongerik Atolls. / Crew members of YAG 39 (USS GEORGE EASTMAN), USS PATAPSCO (AOG 1), or YAG 40 (GRANVILLE S. HALL). USS PHILIP (average crew) 3.56 1350
CASTLE Low-Dose Ship-Based Personnel Personnel on ships at Operation CASTLE that received light fallout and transient ships. Personnel on Operation CASTLE ships that received heavy fallout (distinct EPG, see above). / Shore excursions on Rongelap or Rongerik Atolls. / Were crew members of YAG 39 (USS GEORGE EASTMAN), USS PATAPSCO (AOG 1), or YAG 40 (GRANVILLE S. HALL). USS ESTES 1.76 4,300
CASTLE Land-Based Personnel Army, Navy, and Air Force personnel stationed at Enewetak Atoll, Kwajalein Atoll, and weather station islands. Excursions on Rongelap or Rongerik Atolls. 7126th Army Unit stationed at Enewetak Island 1.09 2,600

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). See “Appendix B-5, Operation CASTLE” of the NTPR/RDA SOP Manual for estimated dose.

 

Expedited Processing Group for Operation WIGWAM (1955)

Table A5-9: Expedited Processing Group for Operation WIGWAM (1955)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)† Number of Participants (Approx.)
WIGWAM Ship-Based Personnel All participants. Individuals who performed large scale ship decontamination. USS CHANTICLEER 0.13 6,200

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). See “Appendix B-6, Operation WIGWAM” of the NTPR/RDA SOP Manual for estimated dose.

 

Expedited Processing Groups for Operation REDWING (1956)

Table A5-10: Expedited Processing Groups for Operation REDWING (1956)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)† Number of Participants (Approx.)
REDWING Ship-Based Personnel Military personnel who were assigned to a ship that participated in Operation REDWING activities including transient ships. None specific to this group. USS SILVERSTEIN 1.4 est. 6,000
REDWING Land-Based Personnel Military personnel who supported Operation REDWING and resided on Enewetak Atoll, Kwajalein Atoll, or weather station islands during Operation REDWING. None specific to this group. 7126th Army Unit 3.6 4,000

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). See “Appendix B-7, Operation REDWING” of the NTPR/RDA SOP Manual for estimated doses.

 

Expedited Processing Groups for Operation HARDTACK I (1958)

Table A5-11: Expedited Processing Groups for Operation HARDTACK I (1958)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)‡ Number of Participants (Approx.)
HARDTACK I Ship-Based Personnel Personnel on ships at Operation HARDTACK I, including transient ships. Crew Members of ships that only participated in shots at Johnston Island (distinct EPG, see below). / Crew Members of ships that served as unmanned target vessels for the underwater shots WAHOO and UMBRELLA, to include three destroyers (KILLEN, HOWORTH, and FULLAM), a liberty ship (SS MICHAEL MORAN), and a submarine (BONITA). USS ARIKARA 1.55 6,000
HARDTACK I Non-exposed Ship-Based Personnel All ships that only participated in Shots at Johnston Atoll. Individuals with non-zero film badge doses. USS EPPERSON (DDE-719) NPE† 1,000
HARDTACK I Land-Based Personnel Personnel resident on Parry and Enewetak Islands of Enewetak Atoll and Eneu Island of Bikini Atoll. Personnel who resided on Japtan Island during the operation. / Personnel assigned to Johnston Island. TG 7.1 (Scientific Group stationed on Parry Island) 1.9 3,500

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† NPE stands for no potential for exposure.
‡ These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). See “Appendix B-8, Operation HARDTACK I” of the NTPR/RDA SOP Manual for estimated dose.

 

Expedited Processing Groups for Operation DOMINIC I (1962)

Table A5-13: Expedited Processing Groups for Operation DOMINIC I (1962)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)‡ Number of Participants (Approx.)
DOMINIC I Personnel All participants in DOMINIC I. Crewmembers of USS SIOUX (ATF 75), USC&GSS PIONEER (OSS-31), and USS MONTICELLO (LSD-35) during Shot SWORDFISH. / Personnel involved in the recovery/handling of radioactively contaminated instrumented pods and rocket nose cones associated with successful THOR missile and rocket launches. / Personnel involved in recovery and decontamination operations after any of the THOR missile incidents during Shots BLUEGILL, STARFISH, BLUEGILL PRIME. / Personnel involved in recovery, servicing, or boarding of target rafts after airdrop shots. / Personnel involved in the recovery and handling of other contaminated with radioactive materials due to neutron activation. N/A NPE† 25,000

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† NPE stands for no potential for exposure.
‡ These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). See “Appendix B-10, Operation DOMINIC I” of the NTPR/RDA SOP Manual.

 

Expedited Processing Groups for Nevada Test Site (NTS)

Table A5-14: Expedited Processing Groups for Nevada Test Site (NTS)
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)§ Number of Participants (Approx.)
NTS Observer and Maneuver Troops, 1951–1962 Personnel that participated as a member of ground-based official EDR observer groups or maneuver groups during NTS shots from 1951 through 1962, including Exercise IVY FLATS at DOMINIC II. Members of 505th Military Police Battalion that performed traffic control or march guide activities during UPSHOT-KNOTHOLE (1953) or TEAPOT (1955). Individuals who participated in one of the Volunteer Observer Programs conducted during some of the test series. / Any individuals who participated in more than one maneuver group at more than one shot. / The following maneuver groups are excluded and are each evaluated as a distinct EPG: The 2nd MCPAEB at Operation UPSHOT-KNOTHOLE, Shot BADGER / Task Force WARRIOR at Operation PLUMBBOB, Shot SMOKY. UPSHOT-KNOTHOLE SIMON BCT-A 3.2 42,600
NTS Participants with no Forward Area Activities, 1951–1962 Support personnel stationed at Camp Desert Rock, Camp Mercury, Indian Springs Air Force Base, or Nellis Air Force Base during any single operation from 1951 through 1962 who did not conduct any activities in any NTS forward area. Inter-operational personnel at CDR, Camp Mercury, and Indian Springs Air Force Base. None specific for this group. UPSHOT-KNOTHOLE CDR support troops 0.02 Unknown
Operation UPSHOT-KNOTHOLE 2nd Marine Corps Provisional Atomic Exercise Brigade (2MCPAEB) Marines that participated in the maneuver at UPSHOT-KNOTHOLE Shot BADGER (1953). Marine Helicopter Transport Group 16 that conducted air operations during the 2MCPAEB activities at Shot BADGER. / Personnel in the 2MCPAEB Provisional Helicopter Atomic Test Unit that participated in the Operational Helicopter Test Program at several shots including Shot BADGER. 2nd MCPAEB HQ‡ 3.7 2,167
Operation PLUMBBOB Task Force WARRIOR (TFW) Army infantry troop test Task Force WARRIOR conducted at PLUMBBOB Shot SMOKY (1957). Canadian Army Platoon (7th Platoon, Queen's Own Rifles). / 3rd Transportation Battalion (Helicopter). / Personnel not in an element of Company C, 1st Battle Group whose activities are not encompassed by the TFW highest-dose cohort scenario. 2nd Platoon 0.7 350

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
‡ Members of 1st Battalion 8th Marines of the 2nd MCPAEB received a higher total dose from external residual radiation (4.7 rem) than did the 2nd MCPAEB HQ personnel. However, no internal dose was accrued concurrently with approximately half of this total dose that was due to direct radiation from the BADGER stem as it passed the troops. Most of the dose to 2nd MCPAEB HQ personnel was from fallout, for which internal dose was concurrently accrued.
§ These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). See Appendices C-3 to C-7 of the NTPR/RDA SOP Manual for estimated dose.

 

Expedited Processing Groups for PPG Post Operations

Table A5-15: Expedited Processing Groups for PPG Post Operations
Proposed EPG* EPG Members Exclusions (Units, cohorts, activities, etc.) Highest-Dose Cohort Estimated External Residual Gamma Dose for the Highest-Dose Cohort (rem)† Number of Participants (Approx.)
Post-SANDSTONE Enewetak Atoll Residents of Enewetak Atoll on the islands of Enewetak, Parry and Japtan. None specific for this group. Residents of Enewetak Island 0.05 1,900
Post-GREENHOUSE Enewetak Atoll Residents of Enewetak Atoll on the islands of Enewetak, Parry and Japtan. None specific for this group. Residents of Parry Island 2.4 2,600
Post-IVY Enewetak Atoll Residents of Enewetak Atoll on the islands of Enewetak, Parry and Japtan. None specific for this group. Residents of Enewetak Island 0.028 600
Post-CASTLE Enewetak Atoll Residents of Enewetak Atoll on the islands of Enewetak, Parry and Japtan. None specific for this group. Residents of Enewetak Island 0.25 1,000
Post-REDWING Enewetak Atoll Residents of Enewetak Atoll on the islands of Enewetak, Parry and Japtan. None specific for this group. Residents of Parry Island 1.9 4,500
Post-HARDTACK I Enewetak Atoll Residents of Enewetak Atoll on the islands of Enewetak and Parry. Individuals who resided on Japtan Island. Residents of Enewetak Island 0.56 973

* Detailed descriptions with complete lists of ships, cohorts, excluded units, etc., are included in the EPG Compendium (Case et al., 2011b).
† These are not assigned doses to members of EPGs (see the introductory narrative of this attachment). All listed doses are from NTPR-TM-09-02, Doses Accrued at the Residence Islands of Enewetak Atoll from Previous Operations (December 31, 2009).

 

Organ Doses Corresponding to the Limiting Doses and Screening Doses

Table A6-1: Organ Doses Corresponding to the Limiting Doses and Screening Doses
Cancer of Organ/Disease Limiting Dose (rem) at 40% PC* Screening Dose (rem) at 50% PC*†
Acute Lymphocytic Leukemia (ALL) 14‡ 24‡
Acute Myeloid Leukemia (AML) 20‡ 29‡
All digestive, other than esophagus, stomach, colon, and rectum/anus 44 66
All male genitalia 41 60
Bladder 33 49
Bone 32 48
Breast 36 53
Chronic Lymphocytic Leukemia (CLL) 45 68
Chronic Myeloid Leukemia (CML) 41‡ 57‡
Colon 26 39
Connective tissue 34 50
Endocrine glands, other than thyroid 30 45
Esophagus 22 35
Eye 32 49
Female Genitalia, excluding ovary n/a n/a
Gallbladder 11 17
Leukemia, excluding ALL, AML, CML, and CLL 29‡ 41‡
Liver 7.7 11
Lung (with option "never smoker") 30 44
Lymphoma and multiple myeloma 41 61
Nervous system 64 95
Oral cavity and Pharynx 66 98
Other and ill-defined sites 34 51
Ovary n/a n/a
Pancreas 61 89
Rectum 72 110
Respiratory tract, other than lung 67 100
Stomach 18 27
Thyroid 5.1** 7.5**
Urinary organs, excluding bladder 31 46

* Probability of Causation (PC) is calculated for exposure at age 18 years and attained age of 50 years (elapsed time of 32 years) unless noted otherwise.
† From Kocher and Apostoaei (2007).
‡ PC is calculated for an elapsed time of 30 years.
§ From Mannis et al. (2013).
** PC is calculated for an elapsed time of >10 years.

 

Estimated Radiation Dose (rem) for Ship-Based Personnel at the Pacific Proving Ground*

Table A7-1: Estimated Radiation Dose (rem) for Ship-Based Personnel at the Pacific Proving Ground*
EPG Name* Radiation Type† Adrenals Bone Surface Brain Breast Stomach wall Small Intestine wall Upper Large Intestine Wall Lower Large Intestine Wall Kidneys Liver Extra-Thoracic Region Lung Muscle Pancreas Red Marrow Spleen Testes Thymus Thyroid Urinary Bladder Wall
XRDS Target Ships UB α 0.09 47 0.09 0.09 0.09 0.09 0.09 0.09 0.2 11 0.5 1 0.09 0.09 3 0.09 0.7 0.09 0.09 0.09
Ext Dose Upper Bound UB β+γ 0.3 3 0.2 0.2 0.9 2 8 19 0.4 0.7 9 19 0.3 0.3 0.9 0.3 0.2 0.3 45 0.6
3 9 total 9 58 9 9 10 11 17 28 10 20 19 28 9 9 12 9 10 9 53 10
XRDS Support Ships UB α 0.003 2 0.003 0.003 0.003 0.003 0.003 0.003 0.006 0.3 0.02 0.03 0.003 0.003 0.07 0.003 0.02 0.003 0.003 0.003
Ext Dose Upper Bound UB β+γ 0.009 0.09 0.005 0.006 0.04 0.08 0.4 0.9 0.02 0.03 0.2 0.4 0.009 0.01 0.04 0.008 0.007 0.007 2 0.03
3 9 total 9 10 9 9 9 9 9 10 9 9 9 9 9 9 9 9 9 9 10 9
USS BRUSH UB α 0.09 51 0.09 0.09 0.1 0.1 0.2 0.2 0.3 11 0.5 1 0.09 0.09 3 0.09 0.7 0.09 0.09 0.09
Ext Dose Upper Bound UB β+γ 0.3 3 0.2 0.2 0.5 1 5 13 0.3 0.6 0.5 4 0.2 0.3 0.8 0.2 0.2 0.2 0.2 0.3
0.08 0.3 total 0.6 53 0.5 0.5 0.9 2 5 13 0.7 12 2 5 0.6 0.6 4 0.6 2 0.6 0.6 0.6
SANDSTONE Ships UB α <0.001 0 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Ext Dose Upper Bound UB β+γ <0.001 0 <0.001 <0.001 <0.001 0.002 0.006 0.02 <0.001 <0.001 0.02 0.03 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.03 <0.001
0.09 0.3 total 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
GREENHOUSE Ships UB α <0.001 0.1 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.03 <0.001 0.003 <0.001 <0.001 0.005 <0.001 0.002 <0.001 <0.001 <0.001
Ext Dose Upper Bound UB β+γ 0.02 0.2 0.01 0.02 0.1 0.2 0.7 2 0.02 0.03 2 3 0.02 0.02 0.06 0.02 0.009 0.02 3 0.06
3 7 total 7 7 7 7 7 7 7 8 7 7 9 9 7 7 7 7 7 7 9 7
IVY Ships UB α <0.001 0.03 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.005 <0.001 <0.001 <0.001 <0.001 0.002 <0.001 <0.001 <0.001 <0.001 <0.001
Ext Dose Upper Bound UB β+γ <0.001 0.02 <0.001 <0.001 0.002 0.004 0.02 0.04 <0.001 0.004 0.05 0.08 <0.001 <0.001 0.002 <0.001 <0.001 <0.001 0.05 <0.001
0.07 0.2 total 0.2 0.3 0.2 0.2 0.2 0.2 0.3 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2
CASTLE Ships (High) UB α 0.009 5 0.009 0.009 0.009 0.009 0.009 0.009 0.03 1 0.05 0.2 0.009 0.009 0.3 0.009 0.07 0.009 0.009 0.009
Ext Dose Upper Bound UB β+γ 0.2 5 0.08 0.2 1 2 7 13 0.3 0.8 21 24 0.2 0.2 0.5 0.2 0.2 0.2 16 0.5
8 23 total 23 32 23 23 24 25 30 36 23 25 43 47 23 23 24 23 23 23 38 23
CASTLE Ships (Low) UB α 0.02 7 0.02 0.02 0.02 0.02 0.02 0.02 0.03 2 0.07 0.2 0.02 0.02 0.4 0.02 0.1 0.02 0.02 0.02
Ext Dose Upper Bound UB β+γ 0.08 5 0.04 0.07 0.4 0.7 3 6 0.2 0.9 8 12 0.07 0.08 0.4 0.07 0.08 0.09 7 0.2
4 12 total 12 22 12 12 12 13 15 17 12 14 20 23 12 12 13 12 12 12 18 12
WIGWAM Ships UB α <0.001 .02 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 .03 0.002 0.003 <0.001 <0.001 0.006 <0.001 0.002 <0.001 <0.001 <0.001
Ext Dose Upper Bound UB β+γ 0.007 0.1 0.004 0.006 0.04 0.07 0.3 0.5 0.007 0.009 0.8 0.7 0.006 0.007 0.02 0.006 0.004 0.007 1 0.03
0.3 0.6 total 0.6 0.8 0.6 0.6 0.6 0.7 0.9 1 0.6 0.6 2 2 0.6 0.6 0.6 0.6 0.6 0.6 2 0.6
REDWING Ships UB α <0.001 .01 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 .02 <0.001 0.002 <0.001 <0.001 0.005 <0.001 0.002 <0.001 <0.001 <0.001
Ext Dose Upper Bound UB β+γ 0.01 0.1 0.005 0.008 0.05 0.09 0.4 0.8 0.02 0.02 2 2 0.009 0.01 0.03 0.008 0.005 0.02 2 0.03
3 7 total 7 7 7 7 7 7 7 7 7 7 8 8 7 7 7 7 7 7 8 7
HARDTACK I Ships UB α .003 2 .003 .003 .003 .003 .003 .003 .007 .04 .02 .04 .003 .003 .08 .003 .03 .003 .003 .003
Ext Dose Upper Bound UB β+γ 0.003 0.4 0.02 0.03 0.08 0.2 0.8 2 0.2 0.09 3 3 0.03 0.03 0.09 0.2 0.02 0.03 3 0.2
2 6 total 6 8 6 6 6 6 7 8 6 7 9 9 6 6 6 6 6 6 9 6
HARDTACK I Non- Exposed Ships UB α No Potential for Exposure (NPE)
Ext Dose Upper Bound UB β+γ No Potential for Exposure
NPE+ NPE+ total No Potential for Exposure
ARGUS Ships UB α No Potential for Exposure
Ext Dose Upper Bound UB β+γ No Potential for Exposure
NPE+ NPE+ total No Potential for Exposure
DOMINIC I Ships UB α No Potential for Exposure
Ext Dose Upper Bound UB β+γ No Potential for Exposure
NPE+ NPE+ total No Potential for Exposure

* The total organ doses do not sum up to their components due to rounding.
† UB means upper bound dose for the given radiation type: internal alpha (α), internal beta plus gamma (β+γ), or total (external γ dose plus internal α and β+γ dose, excluding any initial external γ dose ).
+ NPE means no potential for exposure.

 

Estimated Radiation Doses (rem) for Land-Based Personnel at the Pacific Proving Ground*

Table A7-2: Estimated Radiation Doses (rem) for Land-Based Personnel at the Pacific Proving Ground*
EPG Name Radiation Type† Adrenals Bone Surface Brain Breast Stomach wall Small Intestine wall Upper Large Intestine Wall Lower Large Intestine Wall Kidneys Liver Extra-Thoracic Region Lung Muscle Pancreas Red Marrow Spleen Testes Thymus Thyroid Urinary Bladder Wall
CROSSROADS Land UB α 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Ext Dose Upper Bound UB β+γ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0.03 0.09 total 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09
BIKINI Resurvey UB α 0.09 49 0.09 0.09 0.09 0.09 0.09 0.09 0.3 11 0.5 1 0.09 0.09 3 0.09 0.7 0.09 0.09 0.09
Ext Dose Upper Bound UB β+γ 0.02 1 0.007 0.01 0.02 0.03 0.1 0.3 0.01 0.3 0.2 3 0.008 0.01 0.08 0.01 0.02 0.02 0.008 0.008
0.8 3 total 3 52 3 3 3 3 3 3 3 14 3 6 3 3 5 3 4 3 3 3
SANDSTONE Land UB α <0.001 0.5 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.002 0.1 0.005 0.01 <0.001 0.002 0.03 0.003 0.006 <0.001 0.002 <0.001
Ext Dose Upper Bound UB β+γ 0.007 0.07 0.003 0.006 0.02 0.03 0.2 0.3 0.005 0.02 0.4 0.8 0.005 0.006 0.03 0.005 0.003 0.007 0.6 0.01
0.2 0.6 total 0.6 1 0.6 0.6 0.6 0.6 0.7 0.8 0.6 0.7 0.9 2 0.6 0.6 0.6 0.6 0.6 0.6 1 0.6
GREENHOUSE Land UB α 0.005 3 0.005 0.005 0.005 0.005 0.005 0.005 0.02 0.6 0.03 0.06 0.005 0.005 0.2 0.005 0.04 0.005 0.005 0.005
Ext Dose Upper Bound UB β+γ 0.2 2 0.08 0.2 0.9 2 5 8 0.2 0.3 12 15 0.2 0.2 0.5 0.2 0.06 0.2 16 0.4
7 21 total 21 25 21 21 22 23 26 29 21 22 33 36 21 21 22 21 21 21 36 22
IVY Land UB α 0.002 2 0.002 0.002 0.002 0.002 0.002 0.002 0.004 0.3 0.02 0.03 0.002 0.002 0.06 0.002 0.02 0.002 0.002 0.002
Ext Dose Upper Bound UB β+γ 0.02 0.7 0.007 0.02 0.04 0.08 0.4 0.7 0.02 0.2 1 3 0.02 0.02 0.08 0.02 0.009 0.02 0.8 0.02
0.2 0.4 total 0.4 3 0.4 0.4 0.4 0.5 0.7 1 0.4 0.7 2 3 0.4 0.4 0.5 0.4 0.4 0.4 2 0.4
CASTLE Land UB α 0.02 7 0.02 0.02 0.02 0.02 0.02 0.02 0.03 2 0.07 0.2 0.02 0.02 0.4 0.02 0.1 0.02 0.02 0.02
Ext Dose Upper Bound UB β+γ 0.1 5 0.05 0.08 0.5 0.9 4 7 0.2 0.9 11 15 0.08 0.09 0.4 0.08 0.08 0.1 8 0.2
2 5 total 5 16 5 5 6 6 8 12 5 7 16 20 5 5 6 5 5 5 13 5
REDWING Land UB α 0.02 9 0.02 0.02 0.02 0.02 0.02 0.02 0.04 2 0.09 0.2 0.02 0.02 0.5 0.02 0.2 0.02 0.02 0.02
Ext Dose Upper Bound UB β+γ 0.2 5 0.2 0.2 2 3 9 16 0.4 0.9 25 30 0.2 0.2 0.7 0.2 0.2 0.3 23 0.6
6 18 total 19 31 18 18 20 21 27 34 19 21 43 48 18 18 19 18 19 19 41 19
HARDTACK I Land UB α 0.02 12 0.02 0.02 0.02 0.02 0.02 0.02 0.06 3 0.2 0.3 0.02 0.02 0.6 0.02 0.2 0.02 0.02 0.02
Ext Dose Upper Bound UB β+γ 0.2 3 0.07 0.2 0.4 0.8 4 8 0.6 0.6 12 11 0.2 0.2 0.5 0.5 0.08 0.2 11 0.6
3 8 total 8 22 8 8 8 9 12 16 9 11 20 19 8 8 9 9 8 8 19 9
DOMINIC I Land UB α No Potential for Exposure
Ext Dose Upper Bound UB β+γ No Potential for Exposure
NPE⁺ NPE⁺ total No Potential for Exposure

* The total organ doses do not sum up to their components due to rounding.
† UB means upper bound dose for the given radiation type: internal alpha (α), internal beta plus gamma (β+γ), or total (external γ dose plus internal α and β+γ dose, excluding any initial external γ dose ).
+ NPE means no potential for exposure.

 

Estimated Radiation Doses (rem) for Post-Operations Personnel at the Pacific Proving Ground*

Table A7-3: Estimated Radiation Doses (rem) for Post-Operations Personnel at the Pacific Proving Ground*
EPG Name Radiation Type† Adrenals Bone Surface Brain Breast Stomach wall Small Intestine wall Upper Large Intestine Wall Lower Large Intestine Wall Kidneys Liver Extra-Thoracic Region Lung Muscle Pancreas Red Marrow Spleen Testes Thymus Thyroid Urinary Bladder Wall
POST-SANDSTONE UB α <0.001 0.08 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.02 <0.001 0.002 <0.001 <0.001 0.004 <0.001 0.002 <0.001 <0.001 <0.001
Ext Dose Upper Bound UB β+γ 0.002 0.02 <0.001 0.002 0.002 0.002 0.009 0.03 <0.001 0.003 0.03 0.2 <0.001 <0.001 0.005 <0.001 <0.001 0.002 0.009 <0.001
0.05 0.2 total 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2
POST-GREENHOUSE UB α 0.004 3 0.004 0.004 0.004 0.004 0.004 0.004 0.009 0.5 0.03 0.05 0.004 0.004 0.1 0.004 0.03 0.004 0.004 0.004
Ext Dose Upper Bound UB β+γ 0.06 0.6 0.02 0.05 0.07 0.2 0.5 2 0.04 0.1 2 7 0.04 0.05 0.3 0.04 0.02 0.06 2 0.04
3 8 total 8 10 8 8 8 8 8 9 8 8 9 14 8 8 8 8 8 8 9 8
POST_IVY UB α <0.001 0.2 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.03 0.002 0.003 <0.001 <0.001 0.006 <0.001 0.002 <0.001 <0.001 <0.001
Ext Dose Upper Bound UB β+γ <0.001 0.07 <0.001 <0.001 <0.001 <0.001 0.004 0.009 <0.001 0.02 0.02 0.05 <0.001 <0.001 0.004 <0.001 <0.001 <0.001 0.01 <0.001
0.03 0.09 total 0.09 0.3 0.09 0.09 0.09 0.09 0.09 0.1 0.09 0.2 0.1 0.2 0.09 0.09 0.1 0.09 0.09 0.09 0.1 0.09
POST-CASTLE UB α 0.006 3 0.006 0.006 0.006 0.006 0.006 0.006 0.02 0.7 0.03 0.07 0.006 0.04 0.006 0.2 0.006 0.006 0.05 0.006
Ext Dose Upper Bound UB β+γ 0.008 2 0.005 0.008 0.008 0.02 0.04 0.1 0.008 0.4 0.2 0.8 0.006 0.03 0.007 0.08 0.005 0.007 0.03 0.009
0.3 0.8 total 0.8 6 0.8 0.8 0.8 0.8 0.8 0.9 0.8 2 0.9 2 0.8 0.8 0.8 1 0.8 0.8 0.8 0.8
POST-REDWING UB α 0.02 8 0.02 0.02 0.02 0.02 0.02 0.02 0.04 2 0.08 0.2 0.02 0.02 0.4 0.02 0.2 0.02 0.02 0.02
Ext Dose Upper Bound UB β+γ 0.05 3 0.02 0.05 0.06 0.09 0.4 1 0.04 0.5 2 7 0.03 0.04 0.3 0.04 0.04 0.06 0.8 0.03
2 6 total 6 16 6 6 6 6 7 7 6 8 7 12 6 6 7 6 6 6 7 6
POST-HARDTACK I UB α 0.006 4 0.006 0.006 0.006 0.006 0.006 0.006 0.02 0.7 0.04 0.08 0.006 0.006 0.2 0.006 0.05 0.006 0.006 0.006
Ext Dose Upper Bound UB β+γ 0.009 0.5 0.004 0.007 0.02 0.02 0.2 0.4 0.06 0.1 0.4 1 0.005 0.007 0.05 0.05 0.007 0.008 0.02 0.02
0.4 1 total 1 5 1 1 1 1 2 2 2 2 2 3 1 1 2 2 2 1 1 1

* The total organ doses do not sum up to their components due to rounding.
† UB means upper bound dose for the given radiation type: internal alpha (α), internal beta plus gamma (β+γ), or total (external γ dose plus internal α and β+γ dose, excluding any initial external γ dose ).

 

Estimated Radiation Doses (rem) for Personnel at the Nevada Test Site*

Table A7-4: Estimated Radiation Doses (rem) for Personnel at the Nevada Test Site*
EPG Name Radiation Type† Adrenals Bone Surface Brain Breast Stomach wall Small Intestine wall Upper Large Intestine Wall Lower Large Intestine Wall Kidneys Liver Extra-Thoracic Region Lung Muscle Pancreas Red Marrow Spleen Testes Thymus Thyroid Urinary Bladder Wall
NTS Obs/Man UB α 0.008 5 0.008 0.008 0.008 0.008 0.008 0.008 0.02 1 0.05 0.1 0.008 0.008 0.3 0.008 0.06 0.008 0.008 0.008
Ext Dose Upper Bound UB β+γ 0.02 0.2 0.006 0.01 0.05 0.07 0.2 0.4 0.009 0.03 0.7 2 0.009 0.02 0.05 0.01 0.005 0.02 0.8 0.02
4 10 total 10 14 10 10 10 10 10 10 10 11 11 11 10 10 10 10 10 10 11 10
NTS Support Troops UB α 0.007 4 0.007 0.007 0.007 0.007 0.007 0.007 0.02 0.8 0.04 0.08 0.007 0.007 0.2 0.007 0.05 0.007 0.007 0.007
Ext Dose Upper Bound UB β+γ <0.001 0.05 <0.001 <0.001 0.006 0.009 0.03 0.05 <0.001 0.02 0.09 0.09 <0.001 <0.001 0.004 <0.001 0.001 0.001 0.2 0.003
0.04 0.1 total 0.2 4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.9 0.3 0.3 0.2 0.2 0.3 0.2 0.2 0.2 0.3 0.2
2MCPAEB UB α 0.003 2 0.003 0.003 0.003 0.003 0.003 0.003 0.007 0.4 0.02 0.04 0.003 0.003 0.09 0.003 0.03 0.003 0.003 0.003
Ext Dose Upper Bound UB β+γ 0.03 0.3 0.02 0.02 0.2 0.2 0.6 2 0.02 0.04 2 3 0.02 0.02 0.08 0.02 0.009 0.03 2 0.05
6 17 total 17 19 17 17 17 17 17 18 17 17 19 20 17 17 17 17 17 17 19 17
TF WARRIOR UB α 0.02 10 0.02 0.02 0.02 0.02 0.02 0.02 0.05 2 0.2 0.4 0.02 0.02 0.5 0.02 0.2 0.02 0.02 0.02
Ext Dose Upper Bound UB β+γ 0.09 2 0.06 0.07 0.7 1 3 4 0.08 0.4 9 8 0.08 0.09 0.4 0.08 0.06 0.1 9 0.3
2 5 total 5 16 5 5 6 6 8 9 5 7 13 12 5 5 6 5 5 5 13 5

* The total organ doses do not sum up to their components due to rounding.
† UB means upper bound dose for the given radiation type: internal alpha (α), internal beta plus gamma (β+γ), or total (external γ dose plus internal α and β+γ dose, excluding any initial external γ dose ).

 

EPG and Organ Combinations not Recommended for Expedited Processing (shaded cells)

Table A3-1: EPG and Organ Combinations not Recommended for Expedited Processing (shaded cells)
NTPR Standard Organ → Adrenals Bone surface Brain Breast St Wall SI Wall ULI Wall LLI Wall Kidneys Liver ET Region Lung Muscle Pancreas Red Marrow Spleen Testes Thymus Thyroid Bladder Wall
NIOSH-IREP Cancer Model→
ERG ↓		 Other endocrine* Bone Other endocrine* Nervous system Eye Other respiratory* Breast Stomach All digestive* Colon (ULI) Colon (LLI) Rectum Other urinary orgs Liver Gallbladder incl. Bile Duct Esophagus Oral cavity Other respiratory* Lung never smoker Other respiratory* Connective tissue Other & ill-defined All digestive* Other respiratory Pancreas ALL* AML* CML* Leukemia* CLL* All digestive* Male genitalia Lymphoma Other respiratory* Thyroid Other endocrine* Urinary organs Bladder
Pacific Proving Ground, Ship-Based Personnel†
XRDS† Support Ships X X
XRDS† Target Ships X X X X X X
USS BRUSH X X X
SANDSTONE
GREENHOUSE X
IVY
CASTLE (High) X X X X X X X X X X X X
CASTLE (Low) X X X
WIGWAM
REDWING X
HARDTACK I X
HT-I Unexposed
ARGUS
DOMINIC I
Pacific Proving Ground, Land-Based Personnel†
CROSSROADS
Bikini Resurvey (1947) X X X
SANDSTONE
GREENHOUSE X X X X X X X X X X X
IVY
CASTLE X X
REDWING X X X X X X X X X X X
HARDTACK I X X X
Pacific Proving Ground, Inter-Operation Personnel†
Post-SANDSTONE
Post-GREENHOUSE X X
Post-IVY
Post-CASTLE
Post-REDWING X X
Post-HARDTACK I
Nevada Test Site Personnel†
NTS Observer and Maneuver Troops X X X
NTS Support
2MCPAEB (UK) X X X X
Task Force WARRIOR (PB) X

* Other endocrine = Endocrine glands, other than thyroid (Table A6-1); Other respiratory = Respiratory tract, other than lung (Table A6-1); Leukemia = Leukemia, excluding ALL, AML, CML, and CLL (Table A6-1); All digestive = All digestive, other than esophagus, stomach, colon, and rectum/anus (Table A6-1); ALL = Acute Lymphocytic Leukemia; AML = Acute Myeloid Leukemia; CML = Chronic Myeloid Leukemia; CLL = Chronic Lymphocytic Leukemia.
† XRDS = CROSSROADS, HT I = HARDTACK I, UK = UPSHOT-KNOTHOLE, PB = PLUMBBOB, 2MCPAEB = 2nd Marine Corps Provisional Atomic Exercise Brigade.